Hematopoietic growth factors in an age of uncertainty
- PMID: 8917222
- DOI: 10.1016/s0022-3476(96)70138-5
Hematopoietic growth factors in an age of uncertainty
Comment on
-
Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial.J Pediatr. 1996 Nov;129(5):656-60. doi: 10.1016/s0022-3476(96)70145-2. J Pediatr. 1996. PMID: 8917229 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
